ALYSON BENEDETTI: Open Payments
NPI 1194239186 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 16 payments from 9 companies in 2025. Trend: 2023 $827 · 2024 $960 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 3 | $170 |
| AstraZeneca Pharmaceuticals LP | 2 | $157 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Novo Nordisk Inc | 1 | $31 |
| HEARTFLOW, INC. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Assure WCD, FARXIGA, LEQVIO, SHINGRIX, ELIQUIS, Ozempic, FFRct, REPATHA.
Industry payments across KY — which companies pay providers there.
